FGF Family: From Drug Development to Clinical Application
AbstractFibroblast growth factor (FGF) belongs to a large family of growth factors. FGFs use paracrine or endocrine signaling to mediate a myriad of biological and pathophysiological process, including angiogenesis, wound healing, embryonic development, and metabolism regulation. FGF drugs for the treatment of burn and ulcer wounds are now available. The recent discovery of the crucial roles of the endocrine-acting FGF19 subfamily in maintaining homeostasis of bile acid, glucose, and phosphate further extended the activity profile of this family. Here, the applications of recombinant FGFs for the treatment of wounds, diabetes, hypophosphatemia, the development of FGF receptor inhibitors as anti-neoplastic drugs, and the achievements of basic research and applications of FGFs in China are reviewed. View Full-Text
Share & Cite This Article
Hui, Q.; Jin, Z.; Li, X.; Liu, C.; Wang, X. FGF Family: From Drug Development to Clinical Application. Int. J. Mol. Sci. 2018, 19, 1875.
Hui Q, Jin Z, Li X, Liu C, Wang X. FGF Family: From Drug Development to Clinical Application. International Journal of Molecular Sciences. 2018; 19(7):1875.Chicago/Turabian Style
Hui, Qi; Jin, Zi; Li, Xiaokun; Liu, Changxiao; Wang, Xiaojie. 2018. "FGF Family: From Drug Development to Clinical Application." Int. J. Mol. Sci. 19, no. 7: 1875.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.